☰

Vanessa M. Morales-Tirado, Ph.D. - Publications

Affiliations: 
2008 University of Rochester, Rochester, NY 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Tan Y, Mosallanejad K, Zhang Q, O'Brien S, Clements M, Perper S, Wilson S, Chaulagain S, Wang J, Abdalla M, Al-Saidi H, Butt D, Clabbers A, Ofori K, Dillon B, ... ... Morales-Tirado V, et al. IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ. Frontiers in Immunology. 15: 1293883. PMID 38455057 DOI: 10.3389/fimmu.2024.1293883  0.339
2019 King BA, Awh C, Gao BT, Wang J, Kocak M, Morales-Tirado VM, Ballo MT, Wilson MW. Iodine-125 Episcleral Plaque Brachytherapy for AJCC T4 Posterior Uveal Melanoma: Clinical Outcomes in 158 Patients. Ocular Oncology and Pathology. 5: 340-349. PMID 31559245 DOI: 10.1159/000495249  0.335
2016 Chintalapudi SR, Djenderedjian L, Stiemke AB, Steinle JJ, Jablonski MM, Morales-Tirado VM. Isolation and Molecular Profiling of Primary Mouse Retinal Ganglion Cells: Comparison of Phenotypes from Healthy and Glaucomatous Retinas. Frontiers in Aging Neuroscience. 8: 93. PMID 27242509 DOI: 10.3389/Fnagi.2016.00093  0.371
2015 Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, Burdelya LG, Grossniklaus HE. The toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget. PMID 26655090 DOI: 10.18632/Oncotarget.6500  0.327
2015 Thakran S, Zhang Q, Morales-Tirado V, Steinle JJ. Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions. Investigative Ophthalmology & Visual Science. 56: 177-84. PMID 25525174 DOI: 10.1167/Iovs.14-15550  0.312
2013 Zhang Q, Jiang Y, Toutounchian J, Wilson MW, Morales-Tirado V, Miller DD, Yates CR, Steinle JJ. Novel quinic acid derivative KZ-41 prevents retinal endothelial cell apoptosis without inhibiting retinoblastoma cell death through p38 signaling. Investigative Ophthalmology & Visual Science. 54: 5937-43. PMID 23942968 DOI: 10.1167/Iovs.13-12326  0.313
2012 Luszczek W, Morales-Tirado V, Merwe Mvd, Kudo K, Campana D, Pillai A. Abstract 3512: Expanded human regulatory iNKT cells exhibit direct cytotoxicity against hematolymphoid tumor targets Cancer Research. 72: 3512-3512. DOI: 10.1158/1538-7445.Am2012-3512  0.592
2011 Morales-Tirado V, Luszczek W, van der Merwe M, Pillai A. Regulatory immunotherapy in bone marrow transplantation. Thescientificworldjournal. 11: 2620-34. PMID 22262950 DOI: 10.1100/2011/768948  0.387
2011 Kasow KA, Morales-Tirado VM, Wichlan D, Shurtleff SA, Abraham A, Persons DA, Riberdy JM. Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. Clinical Immunology (Orlando, Fla.). 141: 169-76. PMID 21865090 DOI: 10.1016/J.Clim.2011.07.005  0.527
2011 Morales-Tirado V, Wichlan DG, Leimig TE, Street SE, Kasow KA, Riberdy JM. 1α,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clinical Immunology (Orlando, Fla.). 138: 212-21. PMID 21167785 DOI: 10.1016/J.Clim.2010.11.003  0.367
2011 Morales-Tirado V, Merwe MVD, Luszczek W, Pillai A. APC-Independent Expansion of Immunoregulatory Tr1 Cells From Stem Cell Sources for Adoptive Immunotherapy Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.192  0.346
2011 Luszczek W, Morales-Tirado V, Woolard S, Van Der Merwe M, Shook D, Campana D, Pillai A. Expanded Human INKT Cells Exhibit Th2 Polarization and Direct Cytotoxicity Against Hematolymphoid Tumor Targets Biology of Blood and Marrow Transplantation. 17: S214. DOI: 10.1016/J.Bbmt.2010.12.188  0.365
2010 Morales-Tirado V, Sojka DK, Katzman SD, Lazarski CA, Finkelman FD, Urban JF, Fowell DJ. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function. Blood. 115: 3498-507. PMID 20032499 DOI: 10.1182/Blood-2009-07-235754  0.412
2004 Morales-Tirado V, Johannson S, Hanson E, Howell A, Zhang J, Siminovitch KA, Fowell DJ. Cutting edge: selective requirement for the Wiskott-Aldrich syndrome protein in cytokine, but not chemokine, secretion by CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 726-30. PMID 15240657 DOI: 10.4049/Jimmunol.173.2.726  0.688
Show low-probability matches.